Pathstone Family Office’s Arbutus Biopharma ABUS Stock Holding History

Pathstone Family Office’s Portfolio ABUS Stock Details ABUS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$20.3K	Hold
2023 Q2	$23K	Hold
2023 Q1	$30.3K	Sell
2022 Q4	$57.6K	Hold
2022 Q3	$38.1K	Buy
2022 Q2	$27.1K	Hold
2022 Q1	$30K	Buy